PUMA's Fast-R NITRO™ Elite 3 Drops & Launches New Era Of Speed!
Run, don't walk! PUMA has unveiled the much-anticipated Fast-R NITRO™ Elite 3, its fastest-ever running shoe, engineered to aid your pursuit of a new personal best.
Debuting at the Boston Marathon, Fast-R NITRO™ Elite 3 combines state-of-the-art technology with cutting-edge design, providing runners a rate of efficiency that could potentially shave minutes off your race day records – evidenced in a research study conducted by the University of Massachusetts, Amherst.
The study, led by industry specialist Wouter Hoogkamer, concluded that Fast-R NITRO™ Elite 3 provides 3.15% improved running economy*, which for a three-hour marathon runner translates to an unprecedented potential marathon time saving of more than 4 minutes and 30 seconds.
Commenting on the findings, Assistant Professor at the University of Massachusetts Amherst Wouter Hoogkamer, who specialises in the biomechanics and energetics of running, said: 'The most striking result from this study was the consistency of the running economy improvements. For every single participant the numbers showed that running was easiest – requiring the least amount of metabolic energy – in the Fast-R 3. This is remarkable. From years of research we know that our lab-measured improvements in running energetics translate to faster race times.'
Engineered with elite runners and tested on real athletes, Fast-R NITRO™ Elite 3 weighs an astonishing 95 grams less than its predecessor. The decoupled midsole has received a fierce upgrade, with a new NITROFOAM™ ELITE compound providing next-level cushion and responsiveness.
The restructured PWRPLATE offers unrivalled propulsion and elite efficiency, whilst retaining the silhouettes iconic extension through the forefoot and out past the toe – a unique design and performance benefit that was first introduced in the Fast-R NITRO™ Elite 2.
A breathable upper is comprised of premium, lightweight ULTRAWEAVE that ensures comfort and support throughout race day, whilst PUMA's industry leading PUMAGRIP outsole offers multi-surface traction to ensure you make it from start to finish with a new PB front of mind.
Romain Girard, VP of Innovation at PUMA said: 'We redefined the creation process to be completely digital. Optimising this approach has resulted in science and data that proves PUMA is not just competing in the running category, we're leading it. This is a truly generational shoe that sets a new standard for the entire category.'
Ahead of his appearance at the Boston Marathon, Canadian Olympian Rory Linkletter said: 'Make no mistake, Fast-R NITRO™ Elite 3 is the most radical ride I've ever experienced, and I have the Strava receipts to prove it. It's certainly the fastest shoe I've ever laced up.'
Designed with PB Chasers in mind, Fast-R NITRO™ Elite 3 will not only be worn by PUMA's elite runners competing at the Boston and London Marathons, it will also be on the feet of 200 PUMA Project3 participants striving to break their personal bests, and the chance to win US$3,000.
Rena Elmer, 41 from Texas who is aiming to break 2:30 at the Boston Marathon said: 'It's great! I felt so fast and fluid. Definitely my favourite racing shoe and confident I will get a new PR in them.'
Fast-R NITRO™ Elite 3 is available starting 2nd May in limited quantities at selected PUMA retailers and online for RM1,099.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
8 hours ago
- Malaysian Reserve
Argo Corporation Reports First Quarter 2025 Financial Results
TORONTO, May 30, 2025 /CNW/ – Argo Corporation (TSXV: ARGH), (OTCQX: ARGHF) ('Argo' or the 'Company'), a leader in next-generation transit solutions, announced its financial results for the quarter ended March 31, 2025 ('Q1 2025'). All figures are in Canadian dollars unless otherwise noted. Municipal Deployments Argo has made significant progress in the commercialization of its Smart Routing™ technology. The Company's first municipal deployment in the town of Bradford West Gwillimbury launched in the second quarter of 2025, as previously announced by the Company. Argo also announced its landmark $10.9 million 12-month pilot with the City of Brampton in the second quarter of 2025, anticipated to launch later this year. While revenue from these agreements was not reflected in Q1 2025 results, the Company expects to begin recognizing related revenues in the second and third quarters of 2025. Argo continues to advance a robust pipeline of municipal opportunities, positioning the Company for continued growth. Research & Development of Smart Routing™ Transit System In Q1 2025, the Company continued its investment in research and development to enhance its proprietary Smart Routing™ hardware and AI-powered software ecosystem, including vertical integration hardware onboard its Argo X1 electric vehicles. This end-to-end platform combines real-time routing software, electric vehicles and full-service operations to deliver dynamic, on-demand transit services. FoodsUp Inc. The company held a 47.851% interest in FoodsUp Inc. ('FoodsUp') as of March 31, 2025. FoodsUp is one of Canada's leading restaurant supply platforms, with annual revenues of $108 million in fiscal 2024. As previously disclosed, the Company made significant progress towards the divestment of this ownership interest in Q1 2025: Sale of Shares: The Company received approximately $2.5 million in proceeds from the sale of an aggregate of 5,855 subordinate-voting shares of FoodsUp Inc. Option Agreements: The Company entered into two option agreements (collectively, the 'Option Agreements') granting the holders thereof the irrevocable option to purchase up to a total of 45,932 subordinate-voting shares of FoodsUp. If the transactions contemplated by the Option Agreements are fully exercised, the Company has the potential to receive gross proceeds of between $21.6 million and $30.2 million. The Company's ability to complete the transactions provided for in the Option Agreements remain subject to any required approvals, including final approval of the TSX Venture Exchange and approval of the shareholders of the Company. In addition, in the second quarter of 2025, the Company announced that its board of directors declared a special stock dividend (the 'Stock Dividend') intended to provide its legacy shareholders with their proportionate stake in the net proceeds realized upon the eventual sale by the Company of its ownership interest in FoodsUp. Pursuant to the Stock Dividend, all of the Company's common shareholders of record on August 13, 2025 (the 'Record Date') will be entitled to receive, one Preferred Share, Series A of Argo for each common share of Argo held on the Record Date. The payment date for the Stock Dividend is August 20, 2025. Additional details regarding the Stock Dividend can be found in the Company's press release dated May 21, 2025. For detailed information, please refer to Argo's condensed interim consolidated financial statements for the three months ended March 31, 2025, and 2024 ('Q1 2025 Financial Statements') and its management's discussion and analysis of financial condition and results of operations for the three months ended March 31, 2025, and 2024 (the 'Q1 2025 MD&A'), filed on SEDAR+ at The following table provides a summary of Argo's financial results for the three months ended March 31, 2025 and 2024: For the three months ended March 31 2025 2024 REVENUE $512,172 $219,585 Cost of revenue $115,987 $12,956 General and administration 2,570,907 966,946 Operational support 663,431 239,207 Research and development 224,492 49,174 Sales and marketing 10,648 34,802 Provision for trade and other receivables – – Amortization & depreciation 18,490 34,746 Depreciation 25,989 7,584 Total operating expenses 3,629,944 1,345,415 OPERATING LOSS ($3,117,772) ($1,125,830) OTHER INCOME (EXPENSES) Foreign exchange gain/ (loss) (14,791) (40,069) Interest expenses (427,312) (228,616) Interest income – 897 Loss on termination (996,968) – Write-off of accounts payable settlements – 98,202 Fair value gain (loss) on investments 2,726,221 – Gain on sale of investment 105,864 – Share of loss of an associate – (1,083,495) Net income/ (loss) from continuing operations ($1,724,758) ($2,378,911) Discontinued Operations Net gain/(loss) from discontinued operations, net of tax 497 (489,791) Gain from derecognition, net of tax – 1,341,770 NET GAIN (LOSS) ($1,724,261) ($1,526,932) Cumulative translation adjustment (342) 78,655 Cumulative translation adjustment for discontinued operations – (252,661) NET PROFIT (LOSS) AND COMPREHENSIVE PROFIT (LOSS) ($1,724,603) ($1,700,938) (Loss) Profit per share (Loss) income per share from continuing operations – Basic and diluted ($0.01) ($0.02) Income (loss) per share from derecognition and discontinued operations – Basic and diluted $0.00 $0.01 Weighted average shares outstanding – Basic and diluted 138,683,002 132,944,615 All figures rounded to the nearest dollar. Prepared in accordance with IFRS. About Argo Argo delivers the world's first fully vertically integrated transit system, combining Argo X1 electric vehicles, Smart Routing™ technology, and comprehensive operational management in a single end-to-end solution. By integrating every aspect of the transit experience, Argo enables municipalities to augment traditional fixed-route services to dynamically optimized on-demand service while maintaining standard public transit pricing. The company launched Argo School in September 2024 and began its first municipal deployment in Bradford West Gwillimbury in early 2025. Learn more at Praveen Arichandran, CEOArgo Corporation(800) 575-7051 Forward-Looking Information This news release includes certain forward-looking statements as well as management's objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as 'may', 'will', 'plan', 'expect', 'anticipate,' 'estimate,' and 'intend,' and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. The forward- looking information set out in this news release relates to future events or our future performance and includes, without limitation, statements concerning the recognition of revenue in future quarters, the future growth of the Company, the completion of the completion of the exercise of the options granted pursuant to the Option Agreements by the holders thereof, Argo's ability to obtain all necessary approvals in respect of the Option Agreements and the Stock Dividend, and Argo's intention with respect to the Stock Dividend. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, as described in more detail in the Company's securities filings available at Actual events or results may differ materially from those projected in the forward-looking statements, and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. See 'Cautionary Note Regarding Forward-Looking Information', 'Financial Risk Management Objectives And Policies' and 'Other Business Risks and Uncertainties' in the Company's Q1 2025 Financial Statements and its Q1 2025 MD&A for a discussion of the uncertainties, risks and assumptions associated with these statements and other risks. Readers are urged to consider the uncertainties, risks, and assumptions carefully when evaluating forward-looking information and are cautioned not to place undue reliance on such information. We have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities legislation and regulatory requirements. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Barnama
2 days ago
- Barnama
Kinaxis Brings AI-powered Supply Chain Breakthroughs To Tokyo At Kinexions 25
TOKYO, May 29 (Bernama) -- Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain orchestration, today announced it will host Kinexions Japan 25 on Tuesday, June 3, 2025, in Tokyo. This year's event will spotlight new product capabilities and customer strategies designed for complex, fast-changing supply chain environments. Part of the global Kinexions event series, Kinexions Japan brings together supply chain leaders, business decision-makers, and industry experts to reveal how organizations are accelerating decision-making, improving collaboration, and scaling operations with greater resilience. With pressure mounting from disruption, sustainability demands, and economic uncertainty, this year's event delivers practical insights, customer success stories, and strategies that are helping organizations take action today. Attendees will get an early look at Maestro™ features, including faster scenario modeling, integrated planning, and real-time coordination across global operations.
The Sun
2 days ago
- The Sun
Agilis Robotics Achieves Milestone with World's First Robotic-Assisted En Bloc Resection of Bladder Tumour in Collaboration with CUHK
HONG KONG SAR - Media OutReach Newswire - 29 May 2025 - Hong Kong-based Agilis Robotics has reached a major milestone in surgical innovation with the successful completion of the world's first robotic-assisted en bloc resection of bladder tumour (ERBT) in patients. This clinical trial, conducted with The Chinese University of Hong Kong (CUHK), highlights the Intilume™ System's potential to improve precision and safety in minimally invasive surgeries. The trial, conducted since December 2022, involved eight patients with bladder tumours. All procedures achieved complete tumour removal, and six patients who completed 30-day post-surgery observations showed satisfactory recovery. Two patients remain under observation, with all participants discharged within 1–2 days. The Intilume™ System The Intilume™ System is a robotic surgical platform designed to improve precision and stability in minimally invasive procedures. Featuring two dextrous and miniaturised robotic arms (2.8mm–3.5mm in diameter), it enables accurate en bloc tumour resections in confined spaces. Its intuitive controls can reduce reliance on manual dexterity, shorten the learning curve, and enhance outcomes for complex procedures like ERBT. Addressing Bladder Cancer Treatment Challenges Bladder cancer is among the 10 most common cancers globally, with 75% of cases being non-muscle-invasive. ERBT is more effective than conventional transurethral resection (TURBT) in reducing recurrence but requires high surgical expertise and carries bleeding and bladder perforation risks. The Intilume™ System improves stability and precision, minimizing these risks. Dr. Peter CHIU Ka-fung, Associate Professor in CUHK's Division of Urology, remarked: 'The robotic system increases the stability of ERBT operations, reducing the risks of bleeding and perforation, and enhancing surgical precision. It helps lower the risk of recurrence due to residual tumour tissue and speed up patient recovery. Future Applications The Intilume™ System has potential applications beyond bladder cancer, including gastrointestinal, prostate, uterine, and biliary surgeries. Its compatibility with standard endoscopes and adaptable design makes it a versatile tool across various specialties. This milestone underscores Agilis Robotics' commitment to advancing precision in minimally invasive surgery.
